Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?

Abstract

Glucose-dependent insulinotropic polypeptide (GIP or gastric inhibitory polypeptide) is a gastrointestinal hormone, which modulates physiological insulin secretion. Due to its insulinotropic activity, there has been a considerable increase of interest in utilising the hormone as a potential therapy for type 2 diabetes. One of the difficulties in attempting… (More)

Topics

  • Presentations referencing similar topics